CMV-DNA copy number in VR and VI patients during the follow-up period after kidney transplantation.

<p>(A) Follow-up time and CMV-DNA copy number (copies/ml) are shown for representative VR and VI patients by calculating the CMV-AUC as a measure of infection intensity. (B) CMV-AUC in VR patients (n = 26 out of 42 CMV-seropositive patients) and VI patients (n = 7 out of 16 seronegative patients who were infected and subsequently became CMV-seropositive) are illustrated in the box plots. The Mann-Whitney U test was used to compare group values and p-values are depicted in the panels.